SOP: [(2R,3S,4R,5R)-5-(6-AMINO-9H-PURIN-9-YL)-4-HYDROXY-3-(PHOSPHONOOXY)TETRAHYDROFURAN-2-YL]METHYL (3R)-3-HYDROXY-2,2-DIMETHYL-4-OXO-4-{[3-OXO-3-({2-[(2-OXOPROPYL)THIO]ETHYL}AMINO)PROPYL]AMINO}BUTYL DIHYDROGEN DIPHOSPHATE
SOP is a Ligand Of Interest in 9MVA designated by the Author
| Best-fitted instance in this entry | |
| Other instances in this entry |
| Best-fitted instance in this entry | |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9MVA_SOP_F_502 | 89% | 12% | 0.052 | 0.976 | 2.69 | 1.45 | 17 | 11 | 1 | 0 | 100% | 1 |
| 9MVA_SOP_E_502 | 87% | 11% | 0.057 | 0.974 | 2.78 | 1.43 | 14 | 10 | 2 | 0 | 100% | 1 |
| 9MVA_SOP_C_502 | 83% | 11% | 0.062 | 0.968 | 2.8 | 1.36 | 15 | 10 | 2 | 0 | 100% | 0.98 |
| 9MVA_SOP_D_502 | 80% | 11% | 0.068 | 0.964 | 2.89 | 1.39 | 15 | 9 | 2 | 0 | 100% | 1 |
| 9MVA_SOP_A_502 | 78% | 11% | 0.069 | 0.96 | 2.89 | 1.38 | 18 | 9 | 3 | 0 | 100% | 1 |
| 9MVA_SOP_B_502 | 78% | 10% | 0.069 | 0.958 | 2.91 | 1.39 | 17 | 8 | 2 | 0 | 100% | 1 |
| 4PZT_SOP_A_1701 | 89% | 9% | 0.053 | 0.978 | 2.84 | 1.62 | 14 | 16 | 1 | 0 | 100% | 1 |
| 6NBW_SOP_N_400 | 78% | 8% | 0.072 | 0.965 | 2.62 | 2.11 | 15 | 18 | 0 | 0 | 100% | 1 |
| 2FY5_SOP_A_2000 | 58% | 30% | 0.094 | 0.913 | 1.08 | 1.72 | 3 | 13 | 2 | 0 | 100% | 1 |
| 2WLG_SOP_A_1216 | 27% | 11% | 0.146 | 0.839 | 2.07 | 2.1 | 8 | 19 | 24 | 0 | 100% | 0.7 |














